Indirect allorecognition can play an important role in the development of transplant arteriosclerosis.

BACKGROUND Indirect allorecognition has been implicated in the initiation of chronic allograft dysfunction. Our aim was to develop an animal model that allowed the contribution of the direct and indirect pathway of allorecognition in the evolution of transplant arteriosclerosis, the main feature of chronic allograft rejection, to be evaluated. METHODS Aortic allografts mismatched for a single MHC class I antigen were transplanted into athymic NUDE or RAG (-/-) mice. Immunodeficient mice were reconstituted with either CD4(+) (indirect) or CD8(+) (direct + indirect) T cells in the presence or absence of depleting antibodies specific for the opposite T-cell subset. Aortic grafts were analyzed by performing morphometry, immunohistochemistry, and quantitative reverse transcriptase-polymerase chain reaction for the detection of cytokine mRNA production. Donor-specific alloantibody production was measured by fluorescence-activated cell sorter analysis. RESULTS Reconstitution of athymic nude mice with 4 x 10(7) purified CD4(+) T cells resulted in vascular rejection of MHC class I mismatched aortic grafts. Intimal proliferation was 24+/-8% and did not decrease when nude-derived endogenous CD8(+) T cells were depleted from the nude recipients (intimal proliferation, 21+/-7%). Transplant arteriosclerosis initiated by CD4+ T cells was associated with the presence of intragraft mRNA for interferon-gamma, tumor necrosis factor-alpha, inducible nitric oxide synthase, and interleukin 12. Reconstitution of RAG-1(-/-) mice with 4 x 10(7) purified CD4(+) T cells resulted in a similar degree of transplant arteriosclerosis (intimal proliferation, 20+/-9%) in MHC class I mismatched aortic grafts in the absence of alloantibody production. CONCLUSION Indirect recognition of donor MHC class I molecules by CD4(+) T cells can play an important role in the process of transplant arteriosclerosis. CD8(+) T-cell effector function and alloantibody production in this model are dependent on CD4(+) T-cell help after indirect allorecognition.

[1]  K. Wood,et al.  INTRAGRAFT INTERLEUKIN-4 mRNA EXPRESSION AFTER SHORT-TERM CD154 BLOCKADE MAY TRIGGER DELAYED DEVELOPMENT OF TRANSPLANT ARTERIOSCLEROSIS IN THE ABSENCE OF CD8+ T CELLS1 , 2000, Transplantation.

[2]  R. Lechler,et al.  Lack of T cell proliferation without induction of nonresponsiveness after antigen presentation by endothelial cells. , 1999, Transplantation.

[3]  K. Wood,et al.  T-cell activation, proliferation, and memory after cardiac transplantation in vivo. , 1999, Annals of surgery.

[4]  D. Wagner,et al.  Donor MHC and adhesion molecules in transplant arteriosclerosis. , 1999, The Journal of clinical investigation.

[5]  H. Auchincloss,et al.  Direct and indirect recognition: the role of MHC antigens in graft rejection. , 1999, Immunology today.

[6]  D. Zélénika,et al.  CD4 T cells can reject major histocompatibility complex class I‐incompatible skin grafts , 1999, European journal of immunology.

[7]  A. Valujskikh,et al.  Contributions of direct and indirect T cell alloreactivity during allograft rejection in mice. , 1999, Journal of immunology.

[8]  K. Wood,et al.  Donor resting B cells induce indefinite prolongation of fully allogeneic cardiac grafts when delivered with anti-immunoglobulin-D monoclonal antibody: evidence for tolerogenicity of donor resting B cells in vivo. , 1998, Transplantation.

[9]  J. Pober,et al.  Human endothelial cells effectively costimulate cytokine production by, but not differentiation of, naive CD4+ T cells. , 1998, Journal of immunology.

[10]  Polly Matzinger,et al.  A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell , 1998, Nature.

[11]  Richard A. Flavell,et al.  Help for cytotoxic-T-cell responses is mediated by CD40 signalling , 1998, Nature.

[12]  Stephen P. Schoenberger,et al.  T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions , 1998, Nature.

[13]  S. Khoury,et al.  Mechanisms of indirect allorecognition: characterization of MHC class II allopeptide-specific T helper cell clones from animals undergoing acute allograft rejection. , 1998, Transplantation.

[14]  M. Yacoub,et al.  Assessment of the contribution that direct allorecognition makes to the progression of chronic cardiac transplant rejection in humans. , 1998, Circulation.

[15]  R. Ciubotariu,et al.  Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts. , 1998, The Journal of clinical investigation.

[16]  R. Lechler,et al.  Antigen presentation by epithelial cells induces anergic immunoregulatory CD45RO+ T cells and deletion of CD45RA+ T cells. , 1997, Journal of immunology.

[17]  P. Russell,et al.  Alloantibody- and T cell-mediated immunity in the pathogenesis of transplant arteriosclerosis: lack of progression to sclerotic lesions in B cell-deficient mice. , 1997, Transplantation.

[18]  M. Russell,et al.  Sustained anti-CD4/CD8 treatment blocks inflammatory activation and intimal thickening in mouse heart allografts. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[19]  B Murphy,et al.  Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction. , 1997, Transplantation.

[20]  W. Heath,et al.  Induction of a CD8+ Cytotoxic T Lymphocyte Response by Cross-priming Requires Cognate CD4+ T Cell Help , 1997, The Journal of experimental medicine.

[21]  C. Orosz,et al.  Prolonged murine cardiac allograft acceptance: characteristics of persistent active alloimmunity after treatment with gallium nitrate versus anti-CD4 monoclonal antibody. , 1997, Transplantation.

[22]  L. Glimcher,et al.  CD8+ effector cells responding to residual class I antigens, with help from CD4+ cells stimulated indirectly, cause rejection of "major histocompatibility complex-deficient" skin grafts. , 1997, Transplantation.

[23]  J. Pickering,et al.  Intimal Thickening Develops Without Humoral Immunity in a Mouse Aortic Allograft Model of Chronic Vascular Rejection , 1996 .

[24]  G. Trinchieri,et al.  Immunoregulation by interleukin‐12 , 1996, Journal of leukocyte biology.

[25]  L. Glimcher,et al.  Two levels of help for B cell alloantibody production , 1996, The Journal of experimental medicine.

[26]  J. Hosenpud,et al.  Cardiac allograft vasculopathy. Association with cell-mediated but not humoral alloimmunity to donor-specific vascular endothelium. , 1995, Circulation.

[27]  C. Giacomantonio,et al.  Development of a mouse aortic transplant model of chronic rejection , 1995, Microsurgery.

[28]  H. Winn,et al.  Coronary atherosclerosis in transplanted mouse hearts. II. Importance of humoral immunity. , 1994, Journal of immunology.

[29]  H. Winn,et al.  Coronary atherosclerosis in transplanted mouse hearts. I. Time course and immunogenetic and immunopathological considerations. , 1994, The American journal of pathology.

[30]  K. Wood,et al.  Indirect presentation of MHC antigens in transplantation. , 1994, Immunology today.

[31]  D B Corry,et al.  Constructing polycompetitor cDNAs for quantitative PCR. , 1993, Journal of immunological methods.

[32]  D. Dunn,et al.  Predictors of chronic rejection in renal transplant recipients. , 1993, Transplantation proceedings.

[33]  J. Fabre,et al.  Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides , 1992, The Journal of experimental medicine.

[34]  Susumu Tonegawa,et al.  RAG-1-deficient mice have no mature B and T lymphocytes , 1992, Cell.

[35]  M. Fresno,et al.  Synergism between tumor necrosis factor‐α and interferon‐γ on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide‐dependent mechanism , 1992 .

[36]  J. Bradley,et al.  ALLOGRAFT REJECTION IN CD4+ T CELL–RECONSTITUTED ATHYMIC NUDE RATS—THE NONESSENTIAL ROLE OF HOST‐DERIVED CD8+ CELLS1 , 1992, Transplantation.

[37]  J. Bradley,et al.  Processed MHC class I alloantigen as the stimulus for CD4+ T-cell dependent antibody-mediated graft rejection. , 1992, Immunology today.

[38]  A. Mellor,et al.  Tolerance and MHC restriction in transgenic mice expressing a MHC class I gene in erythroid cells. , 1992, International immunology.

[39]  J. Reimann,et al.  Selective Reconstitution of T Lymphocyte Subsets in scid Mice , 1991, Immunological reviews.

[40]  H. Waldmann,et al.  Induction of tolerance in peripheral T cells with monoclonal antibodies , 1990, European journal of immunology.

[41]  J. Bradley,et al.  Cellular requirements for renal allograft rejection in the athymic nude rat , 1989, The Journal of experimental medicine.

[42]  H. Waldmann,et al.  CD4 monoclonal antibody pairs for immunosuppression and tolerance induction , 1987, European journal of immunology.

[43]  H. Waldmann,et al.  Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo , 1984, Nature.

[44]  T. Hünig.  T-cell function and specificity in athymic mice , 1983 .

[45]  R. Lechler,et al.  The question as to why major histocompatibility complex (MHC) a antigens are uniquely powerful primary immunogens and in this respect differ from antigens of the minor systems , 2003 .

[46]  K. Welsh,et al.  Failure of long surviving, passively enhanced kidney allografts to provoke T-dependent alloimmunity. I. Retransplantation of (AS X AUG)F1 kidneys into secondary AS recipients , 1979, The Journal of experimental medicine.

[47]  G. Galfré,et al.  Monoclonal xenogeneic antibodies to murine cell surface antigens: identification of novel leukocyte differentiation antigens , 1978, European journal of immunology.